The Healthcare Design Conference + Expo has extended the deadline to Jan. 23 to submit presentation proposals for the 2026 event.

BostonGene Announces Ten Presentations at the 65th American Society of Hematology Annual Meeting & Exposition Presentations with Leading Institutions Reveal BostonGene’s AI-driven Molecular and ...

SOUTH SAN FRANCISCO, Calif., Nov. 5, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced ...

Collaborative Presentations Showcase BostonGene’s AI-Driven Innovations in Molecular and Immunoprofiling as Essential for Advancing Cancer Therapies Through Microenvironment and Immune Cell ...

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene Corporation, a biomedical software company committed to defining optimal precision medicine-based therapies for cancer patients, today announced that seven ...